CEO and cofounder of Standigm, Jinhan Kim, is introducing the new AI based drug discovery services, ‘Expander’ and ‘Hunter’ at the Bio-Europe 2017 in Berlin, Germany.  Photo credit: Standigm
Caption CEO and cofounder of Standigm, Jinhan Kim, is introducing the new AI based drug discovery services, ‘Expander’ and ‘Hunter’ at the Bio-Europe 2017 in Berlin, Germany. Photo credit: Standigm
Source Standigm
Download
Related Press Releases Links Standigm, an AI based drug discovery company, launched AI drug discovery services publicly at Bio-Europe 2017 in Berlin, Germany